Markus Galler
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimizing PET/CT protocols: is 60-minute [18 F]F-FDG uptake sufficient for cardiac sarcoidosis?
Journal: EJNMMI research
Published: September 18, 2025
AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysis.
Journal: EJNMMI research
Published: March 21, 2025
PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [68Ga]Ga-PSMA-11, [68Ga]Ga-PSMA I&T, and [18F]PSMA-1007.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 04, 2025
Beyond similarities: overall survival and prognostic insights from [¹⁷⁷Lu]Lu-DOTATOC therapy in neuroendocrine tumors.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 08, 2025
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy.
Journal: Cancers
Published: October 19, 2023
ChatGPT: Can You Prepare My Patients for [18F]FDG PET/CT and Explain My Reports?
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 02, 2023
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [177Lu]Lu-DOTATOC.
Journal: Cancers
Published: February 21, 2022
Deterministic and stochastic effects in spreading dynamics: A case study of bovine viral diarrhea.
Journal: Chaos (Woodbury, N.Y.)
Published: October 02, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026